Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002035782-24-000002·Allarity Therapeutics, Inc.
Schedule 13G ownership disclosure
ALLARITY THERAPEUTICS INC
Series A Convertible Redeemable Preferred Stock · CUSIP: 016744401
Event date: 2024-08-19
- Filing-level shares
- 10,000.00
- Percent of class
- 28.6%
- Olmsted Investments LLC
Shares: 10,000.00 · Class: 28.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002035782-24-000002
- Form type
- SCHEDULE 13G
- Filer
- Allarity Therapeutics, Inc.
- CIK
- CIK 1860657
- Filed
- Aug 29, 2024
- Reporting period
- Aug 19, 2024
- Description
- Schedule 13G beneficial ownership